US health authority investigates potential tumor risk linked to Novartis treatment

The US Food and Drug Administration (FDA) is reviewing a possible link between a Novartis drug and an increased risk of tumors.

Published 5j2 sources✓ ConfirmedImportantupdated 5j

≈ 19sSpeed

The fact

The investigation follows reports of adverse events, though no definitive conclusions have been drawn yet.

2 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 2 media sources · identified on November 7, 2026